Thoracic radiation therapy improves the overall survival of patients with extensive-stage small cell lung cancer with distant metastasis (Q84079231)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21563176%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

title

Thoracic radiation therapy improves the overall survival of patients with extensive-stage small cell lung cancer with distant metastasis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21563176%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author name string

Hui Zhu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21563176%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Zongmei Zhou

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21563176%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Yan Wang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21563176%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Nan Bi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21563176%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Qinfu Feng

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21563176%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Junling Li

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21563176%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Jima Lv

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21563176%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Dongfu Chen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21563176%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Yuankai Shi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21563176%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Luhua Wang

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21563176%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

publication date

11 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21563176%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21563176%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

volume

117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21563176%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

issue

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21563176%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

page(s)

5423-5431

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21563176%20AND%20SRC:MED&resulttype=core&format=json

Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database.

31 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26206

7 January 2021

Radiotherapy for small-cell lung cancer-Where are we heading?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26206

7 January 2021

Combined treatment for limited small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26206

7 January 2021

Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26206

7 January 2021

Extensive-stage small-cell lung cancer: evolution of systemic therapy and future directions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26206

7 January 2021

SCLC extensive disease--treatment guidance by extent or/and biology of response?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26206

7 January 2021

Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: A randomized study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26206

7 January 2021

Cisplatin plus etoposide with and without ifosfamide in extensive small-cell lung cancer: a Hoosier Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26206

7 January 2021

Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26206

7 January 2021

Phase II study of sequential triplet chemotherapy, irinotecan and cisplatin followed by amrubicin, in patients with extensive-stage small cell lung cancer: West Japan Thoracic Oncology Group Study 0301.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26206

7 January 2021

A meta-analysis of thoracic radiotherapy for small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26206

7 January 2021

Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26206

7 January 2021

Prophylactic cranial irradiation in extensive small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26206

7 January 2021

Prognostic factors for survival in extensive stage small cell lung cancer (ED-SCLC): the importance of smoking history, socioeconomic and marital statuses, and ethnicity.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26206

7 January 2021

Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26206

7 January 2021

Identifiers

DOI

10.1002/CNCR.26206

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21563176%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1 reference